Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1127289

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the affordability of medicines as a result of the redrafted WHO resolution entitled, Improving the transparency of markets for medicines, vaccines and other health-related technologies proposed by Italy on 29 April 2019.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	255695
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:32:11 answering member 4455 label Biography information for Seema Kennedy
tabling member	4651 label Biography information for Dan Carden

1127107

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chemical Weapons: Salisbury
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will commission a review of the public health response to the Salisbury and Amesbury Novichok incidents in 2018 to inform future policy on the protection of public health.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	255256
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>Public Health England, NHS England and the Department have carried out post-incident reviews into their response to the Salisbury and Amesbury Novichok incidents. These were subsequently discussed within the Department in September of last year.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 16:24:19 answering member 4455 label Biography information for Seema Kennedy
tabling member	242 label Biography information for Sir Christopher Chope

1127174

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many NHS-registered dental practitioners have ceased to provide NHS services in each of the last 10 years.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	255310
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The NHS Business Services Authority collects data on the number of dentists (performers) who provide some National Health Service primary care dental services in each financial year. This data includes information on leavers and joiners. Leavers are defined as dentists who performed NHS activity in one year but then recorded no activity in the following year and Joiners are defined dentists who recorded NHS activity in the later year but who did not record NHS activity in the previous year. The information requested on NHS-registered dental practitioners ceasing to provide NHS services for the last 10 years is attached. Most dentists (associates) work on NHS contracts held by other dentists with NHS England.</p><p>No information is held on the reasons for an individual dentist leaving an NHS contract. Where the dentist is a contract holder the funding returns to NHS England and it is able to re-let the contract. Where the dentist is working on a contract as an associate the contract holder will seek to recruit a replacement dentist. Overall in the last year for which data is available, 2017/18 total numbers of dentists providing some NHS service increased.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255312 question first answered 21/05/2019 16:10:13 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ255310 table formatted.xlsx title NHS Dentists Ceasing NHS Services 2007-2018
tabling member	1533 label Biography information for Dame Diana Johnson

1127175

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many NHS dental practice owners sold their practices to corporate dental bodies in each of the last ten years.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	255311
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>This data is not held centrally.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 16:19:54 answering member 4455 label Biography information for Seema Kennedy
tabling member	1533 label Biography information for Dame Diana Johnson

1127176

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department collects data on NHS dental practitioners’ reasons for leaving the NHS.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	255312
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The NHS Business Services Authority collects data on the number of dentists (performers) who provide some National Health Service primary care dental services in each financial year. This data includes information on leavers and joiners. Leavers are defined as dentists who performed NHS activity in one year but then recorded no activity in the following year and Joiners are defined dentists who recorded NHS activity in the later year but who did not record NHS activity in the previous year. The information requested on NHS-registered dental practitioners ceasing to provide NHS services for the last 10 years is attached. Most dentists (associates) work on NHS contracts held by other dentists with NHS England.</p><p>No information is held on the reasons for an individual dentist leaving an NHS contract. Where the dentist is a contract holder the funding returns to NHS England and it is able to re-let the contract. Where the dentist is working on a contract as an associate the contract holder will seek to recruit a replacement dentist. Overall in the last year for which data is available, 2017/18 total numbers of dentists providing some NHS service increased.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255310 question first answered 21/05/2019 16:10:13 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ255310 table formatted.xlsx title NHS Dentists Ceasing NHS Services 2007-2018
tabling member	1533 label Biography information for Dame Diana Johnson

1127177

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reasons the statistics compiled by the NHS Business Services Authority are not shared in full with dental practice owners.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	255313
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The NHS Business Services Authority collects a wide range of data from dental practices as part of its role as payment agency for National Health Service dental remuneration. A sub set of this data is routinely published by NHS Digital and is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics</a></p><p>A further suite of management information is not routinely published but is directly shared with dental contract holders through the IT system used to manage remuneration known as Compass. Other data held by the NHS Business Services Authority is available by specific request subject to the usual rules on data protection.</p><p>Oversight of the NHS Business Services Authority overall is provided by the Department. The NHS Business Services Authority dental services carry out yearly research into user satisfaction with its services. This includes a survey of dental contract holders. The survey aims to identify areas for further improvement and the results are shared with the Department.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255314 question first answered 21/05/2019 16:15:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	1533 label Biography information for Dame Diana Johnson

1127178

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has collated feedback from NHS dental practitioners and NHS dental owners on the effectiveness of NHS Business Services Authority oversight procedures.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	255314
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The NHS Business Services Authority collects a wide range of data from dental practices as part of its role as payment agency for National Health Service dental remuneration. A sub set of this data is routinely published by NHS Digital and is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics</a></p><p>A further suite of management information is not routinely published but is directly shared with dental contract holders through the IT system used to manage remuneration known as Compass. Other data held by the NHS Business Services Authority is available by specific request subject to the usual rules on data protection.</p><p>Oversight of the NHS Business Services Authority overall is provided by the Department. The NHS Business Services Authority dental services carry out yearly research into user satisfaction with its services. This includes a survey of dental contract holders. The survey aims to identify areas for further improvement and the results are shared with the Department.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255313 question first answered 21/05/2019 16:15:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	1533 label Biography information for Dame Diana Johnson

1127201

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the ongoing negotiations between the NHS and Vertex pharmaceuticals on the price of cystic fibrosis drug Orkambi, if he will set out the priorities for the UK's delegation to the World Health Assembly, 21-26 May 2019; and if they will support the Italian Government's proposed resolution to improve the transparency of markets for drugs, vaccines and other health-related technologies to strengthen states positions when negotiating drug prices with industry.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	255358
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices. It is crucial that patients have access to the most effective and innovative medicines at a price that represents value to the National Health Service. The Government fully supports the approach the National Institute for Health and Care Excellence and NHS England are adopting in the ongoing negotiations with Vertex Pharmaceuticals on access to their portfolio of cystic fibrosis medicines.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 16:22:48 answering member 4455 label Biography information for Seema Kennedy
tabling member	4571 label Biography information for Gill Furniss

1127214

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the draft resolution for consideration by the World Health Assembly in May 2019 on improving the transparency of markets for medicines, vaccines and other health-related technologies, if the Government will withdraw its support for suggested amendments to remove every mention of high prices.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	255380
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255381 255382 question first answered 21/05/2019 16:12:54 answering member 4455 label Biography information for Seema Kennedy
tabling member	4651 label Biography information for Dan Carden

1127215

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the draft resolution for consideration by the World Health Assembly in May 2019 on improving the transparency of markets for medicines, vaccines and other health-related technologies, if the Government will take steps to help ensure that the recommendation to member states calls for mandatory rather than voluntary measures.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	255381
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255380 255382 question first answered 21/05/2019 16:12:54 answering member 4455 label Biography information for Seema Kennedy
tabling member	4651 label Biography information for Dan Carden